Drugs of Abuse: Sympathomimetics.
Amphetamine
Cathinone
Cocaine
MDMA
Methamphetamine
Sympathomimetic
Toxidrome
Journal
Critical care clinics
ISSN: 1557-8232
Titre abrégé: Crit Care Clin
Pays: United States
ID NLM: 8507720
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
19
8
2021
Statut:
ppublish
Résumé
Sympathomimetic drugs comprise a broad category of substances including both illicit and prescribed drugs that have deleterious effects when ingested or abused. The clinical syndromes that result from overstimulation of the sympathetic nervous system by reuptake inhibition of biogenic amines, such as norepinephrine and dopamine, carry significant morbidity. Recognition and awareness of the appropriate supportive measures are required to mitigate life-threatening complications of multiple organ systems. The sympathomimetic toxidrome is recognized by a constellation of symptoms including agitation, hyperthermia, tachycardia, and hypertension, and the primary treatment involves supportive care, including the liberal use of benzodiazepines.
Identifiants
pubmed: 34053702
pii: S0749-0704(21)00013-0
doi: 10.1016/j.ccc.2021.03.002
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Sympathomimetics
0
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
487-499Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have no financial or commercial conflicts of interest.